| Authors: |
Shukla ND; Division of Oncology, Department of Medicine, Stanford University, Stanford, CA., Schroers-Martin JG; Division of Oncology, Department of Medicine, Stanford University, Stanford, CA., Sworder BJ; Division of Oncology, Department of Medicine, Stanford University, Stanford, CA., Kathuria KR; Division of Oncology, Department of Medicine, Stanford University, Stanford, CA., Alig SK; Division of Oncology, Department of Medicine, Stanford University, Stanford, CA., Frank MJ; Division of Blood and Marrow Transplantation and Cellular Therapy, Department of Medicine, Stanford University, Stanford, CA., Miklos DB; Division of Blood and Marrow Transplantation and Cellular Therapy, Department of Medicine, Stanford University, Stanford, CA., Coutre S; Division of Hematology, Department of Medicine, Stanford University, Stanford, CA., Diehn M; Department of Radiation Oncology, Stanford University, Stanford, CA., Khodadoust MS; Division of Oncology, Department of Medicine, Stanford University, Stanford, CA., Roschewski M; Lymphoid Malignancies Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD., Kurtz DM; Division of Oncology, Department of Medicine, Stanford University, Stanford, CA., Alizadeh AA; Division of Oncology, Department of Medicine, Stanford University, Stanford, CA.; Division of Hematology, Department of Medicine, Stanford University, Stanford, CA.; Stanford Cancer Institute, Stanford University, Stanford, CA.; Institute for Stem Cell Biology and Regenerative Medicine, Stanford University, Stanford, CA. |
